These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2951609)

  • 1. D-1 dopamine receptors labelled with 3H-SCH 23390: decrease in the striatum of aged rats.
    Giorgi O; Calderini G; Toffano G; Biggio G
    Neurobiol Aging; 1987; 8(1):51-4. PubMed ID: 2951609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O; De Montis G; Porceddu ML; Mele S; Calderini G; Toffano G; Biggio G
    Brain Res; 1987 Oct; 432(2):283-90. PubMed ID: 2960426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of aging on 3H-SCH 23390 binding sites in the retina and in distinct areas of the rat brain.
    Giorgi O; Porceddu ML; Pepitoni S; Serra GP; Toffano G; Biggio G
    J Neural Transm Gen Sect; 1990; 82(3):157-66. PubMed ID: 2248731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
    Gredal O; Nielsen M; Hyttel J
    Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH; Dvorkin B
    Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain D1 dopamine receptor in alloxan-induced diabetes.
    Salković M; Lacković Z
    Diabetes; 1992 Sep; 41(9):1119-21. PubMed ID: 1386820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal dopaminergic system in ageing.
    Ricci A
    J Auton Pharmacol; 1990; 10 Suppl 1():s19-24. PubMed ID: 2151517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of (+)PHNO and other D2-dopamine agonists to D1-dopamine receptors labelled by [3H]SCH 23390.
    Pettibone DJ; Totaro JA; Clineschmidt BV
    J Neural Transm; 1987; 69(1-2):147-51. PubMed ID: 2953862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors.
    Lévesque D; Di Paolo T
    Life Sci; 1989; 45(19):1813-20. PubMed ID: 2531825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
    Savasta M; Dubois A; Scatton B
    Brain Res; 1986 Jun; 375(2):291-301. PubMed ID: 2942221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.
    Hyttel J; Arnt J
    J Neural Transm; 1987; 68(3-4):171-89. PubMed ID: 2881976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 105(1-2):171-4. PubMed ID: 6149143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA; Bennett JP
    Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.
    Porceddu ML; Ongini E; Biggio G
    Eur J Pharmacol; 1985 Dec; 118(3):367-70. PubMed ID: 2935413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
    Billard W; Ruperto V; Crosby G; Iorio LC; Barnett A
    Life Sci; 1984 Oct; 35(18):1885-93. PubMed ID: 6387355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
    Porceddu ML; Giorgi O; De Montis G; Mele S; Cocco L; Ongini E; Biggio G
    Life Sci; 1987 Aug; 41(6):697-706. PubMed ID: 2956472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postnatal development of dopamine D1 and D2 receptor sites in rat striatum.
    Gelbard HA; Teicher MH; Faedda G; Baldessarini RJ
    Brain Res Dev Brain Res; 1989 Sep; 49(1):123-30. PubMed ID: 2529061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC; Crossman AR; Woodruff GN
    Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.